Other Haematological – Northern Ireland Cancer Trials Network

Trial	AML 18
Cancer Type	Haematological Cancers, Leukaemia, and Other Haematological
Hospital(s)	Belfast City Hospital
Information	AML 18 A Trial For Older Patients With Acute Myeloid Leukaemia And High Risk Myelodysplastic Syndrome
	Click Here to view CancerHelpUK trial summary

Trial	M16-109
Cancer Type	Haematological Cancers and Other Haematological
Hospital(s)	Belfast City Hospital
Information	A Phase II Open-Label Study Evaluating Tolerability And Efficacy of Navitoclax Alone or In Combination With Ruxolitinib in Subjects With Myelofibrosis

Trial	Manifest
Cancer Type	Haematological Cancers and Other Haematological
Hospital(s)	Belfast City Hospital
Information	A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Haematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients with Myelofibrosis)

Trial	MOSAICC
Cancer Type	Haematological Cancers and Other Haematological
Hospital(s)	Belfast City Hospital
Information	MyeloprOliferative NeoplasmS An In-Depth Case-Control Study: A Case-Control Study Of Patients With Myeloproliferative Neoplasms And Non-Blood Relative/Friend Controls